Cancer stem cells in glioblastoma

Раковые стволовые клетки при глиобластоме
Justin Durla Lathia, Jeremy N. Rich, Stephen C. Mack, Erin E. Mulkearns-Hubert, Claudia L.L. Valentim
2015-06-15

cancer stem cellsglioblastomatherapeutic resistancetumor microenvironmenttumorigenic self-renewal
Tissues with defined cellular hierarchies in development and homeostasis give rise to tumors with cellular hierarchies, suggesting that tumors recapitulate specific tissues and mimic their origins. Glioblastoma (GBM) is the most prevalent and malignant primary brain tumor and contains self-renewing, tumorigenic cancer stem cells (CSCs) that contribute to tumor initiation and therapeutic resistance. As normal stem and progenitor cells participate in tissue development and repair, these developmental programs re-emerge in CSCs to support the development and progressive growth of tumors. Elucidation of the molecular mechanisms that govern CSCs has informed the development of novel targeted therapeutics for GBM and other brain cancers. CSCs are not self-autonomous units; rather, they function within an ecological system, both actively remodeling the microenvironment and receiving critical maintenance cues from their niches. To fulfill the future goal of developing novel therapies to collapse CSC dynamics, drawing parallels to other normal and pathological states that are highly interactive with their microenvironments and that use developmental signaling pathways will be beneficial.
1
Developmental programs used by normal stem and progenitor cells re-emerge in glioblastoma cancer stem cells, supporting tumor development and progression.
2
Effective future therapies may need to disrupt cancer stem-cell dynamics by targeting developmental signaling pathways and interactions with the microenvironment.
3
Glioblastoma cancer stem cells operate within an ecological system, actively remodeling their microenvironment while receiving essential maintenance signals from specialized niches.
4
Glioblastoma contains self-renewing, tumorigenic cancer stem cells that contribute to tumor initiation and therapeutic resistance.
5
Molecular understanding of glioblastoma cancer stem-cell regulation has informed the development of targeted therapies for glioblastoma and other brain cancers.

Cancer stem cells in glioblastoma

The self-renewal, tumorigenicity, developmental programs, therapeutic resistance, and microenvironmental interactions of glioblastoma cancer stem cells

Publication Details
Publication Date
2015-06-15
Journal
Publisher
ISSN
Cited by
1667
Access Type
Author Information
Authors
Justin Durla Lathia
Jeremy N. Rich
Stephen C. Mack
Erin E. Mulkearns-Hubert
Claudia L.L. Valentim
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%